ANGO

Angiodynamics Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth 8/10
  • Momentum 5/10
Angiodynamics sales and earnings growth
ANGO Growth
Good
  • Revenue Y/Y 7.26%
  • EPS Y/Y 87.97%
  • FCF Y/Y -651.00%
Angiodynamics gross and profit margin trends
ANGO Profitability
Neutral
  • Gross margin 54.60%
  • EPS margin -9.00%
  • ROIC -32.60%
Angiodynamics net debt vs free cash flow
ANGO Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -32.8

Angiodynamics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗